Jens Juul Holst

Jens Juul Holst

Professor


  1. 2005
  2. Published

    Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O; Haugaard, S B; Holst, Jens Juul; Deacon, C F; Iversen, J; Andersen, U B; Nielsen, J O; Madsbad, S.

    In: HIV Medicine, Vol. 6, No. 2, 03.2005, p. 91-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Enhanced glucagon-like peptide- 1 (GLP-1) response to oral glucose in glucose intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O.; Haugaard, S.B.; Holst, Jens Juul; Deacon, Carolyn F.; Iversen, J.; Andersen, U.B.; Nielsen, J.O.; Madsbad, S.

    In: HIV Medicine, Vol. 6, 2005, p. 91-98.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide-2 (GLP-2) response to enteral intake in children during anti-cancer treatment. / Andreassen, B U; Paerregaard, A; Schmiegelow, K; Rechnitzer, C; Heilman, C; Hartmann, B; Holst, Jens Juul; Michaelsen, K F.

    In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 40, No. 1, 01.2005, p. 48-53.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucagon-like-peptide-2 (GLP-2) response to enteral intake in children during anticancer treatment. / Andreassen, B.U.; Pærregaard, A.; Schmiegelow, K.; Rechnitzer, C.; Hartmann, Bolette; Holst, Jens Juul; Michaelsen, K.F.

    In: Journal of Pediatric Gastroenterology and Nutrition, No. 40, 2005, p. 48-53.

    Research output: Contribution to journalJournal articleResearch

  6. Published

    Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin? / Buemann, B.; Black, E.; Sørensen, T.I.A.; Holst, C.; Toubro, S.; Pedersen, O.; Holst, J.J.; Rasmussen, C.; Astrup, Arne.

    In: International Journal of Obesity, No. 29, 2005, p. 624-631.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    GLP-2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, D.G.; Stoll, B.; Guan, X.; Cui, L.; Chang, X.; Holst, Jens Juul.

    In: Endokrinologiya, No. 146, 2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearch

  8. Published

    Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, Douglas G; Stoll, Barbara; Guan, Xinfu; Cui, Liwei; Chang, Xiaoyan; Holst, Jens Juul.

    In: Endocrinology, Vol. 146, No. 1, 01.2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction. / Carstensen, Marius; Thomsen, Claus; Gotzsche, Ole; Holst, Jens Juul; Schrezenmeir, Jürgen; Hermansen, Kjeld.

    In: The review of diabetic studies : RDS, Vol. 1, No. 4, 2005, p. 175-84.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. / Deacon, Carolyn F; Holst, Jens J.

    In: International Journal of Biochemistry & Cell Biology, Vol. 38, No. 5-6, 2005, p. 831-44.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, F.; Trautmann, M.; Holst, J.J.; Halseth, A.E.; Nanyakkara, N.; Nielsen, L.; Fineman, M.S.D.; Kim, D.D.; Nauck, M.A.

    In: J. Clin. Endocrinol. Metab., No. 90, 2005, p. 5991-5997.

    Research output: Contribution to journalJournal articleResearch

Previous 1 2 3 4 5 6 Next

ID: 4207